Image For Activity Cover
ORN Spring 2024 - ED Treatment of Opioid Use Disorder: Truth, Trends and Treatments
AVAILABLE ON-DEMAND
Available on-demand. Login or create an account to register to view the recording.
Description:
This lecture is designed to address:
  • Evidence that treatment works
  • Consequences of Inaction
  • Overcoming barriers to evidence based care 
  • Research Testing Innovative Solutions 
Learning objectives:
At the conclusion of this seminar, attendees should be able to:
  1. Evaluate outcomes for Opioid Use Disorder in patients receiving buprenorphine through the Emergency Department and discuss supporting evidence
  2. Identify barriers and solutions to initiating buprenorphine in the Emergency Department
  3. Discuss innovative solutions for buprenorphine induction in the ED including different formulations of buprenorphine and high dose strategies 
Claim Credits & Course Materials

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):
  1. Complete the required course materials.
  2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
What is ORN
Speaker:
Gail D'Onofrio, MD, MS

Gail D'Onofrio, MD, MS is the Albert E. Kent Professor of Emergency Medicine and Professor of Medicine and Public Health in the Schools of Medicine and Public Health at Yale University. She served as the Inaugural Chair of the Department of Emergency Medicine at the Yale School of Medicine from 2009-2022.
Dr. D'Onofrio has extensive experience as a leader, researcher, mentor, and educator.  She is internationally known for her work in alcohol and other substance use disorders as well as her research on gender disparities in the treatment, and outcomes of young individuals with acute ST-elevation myocardial infarction.  As a physician-scientist she has had continual NIH-funding for over two decades designing and conducting clinical trials that have changed clinical practice. 
Dr. D'Onofrio is the PI of the New England Consortium Node (Dr. Weiss Harvard MPI) for the NIDA Clinical Trials Network. She is the PI of a NIDA funded K12 (Dr. O'Connor MPI) "Drug Use, Addiction and HIV Prevention" training program with scholars in multiple disciplines. I She is committed to preparing young faculty to become independent investigators, advancing the science of Emergency Medicine and Addiction.   

Questions for the speaker? email: gail.donofrio@yale.edu.

DISCLAIMER

ACCREDITATION:
This actvity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association and The American Osteopathic Academy of Addiction Medicine (AOAAM). The American Osteopathic Association is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT HOURS:
The American Osteopathic Association designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Funding:

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Summary
Availability: No future session
Expires on Mar 01, 2027
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Recommended
Powered By